Concepedia
Statistics
Publications
5
Citations
200
H-Index
Active since
2022
Affiliations
Texas A&M University(Current)
Sorrento Therapeutics (United States)
Lawrence Berkeley National Laboratory
Jing Xiao is an author at Texas A&M University specializing in virology, drug discovery, and antiviral therapy.
Publications per year
2022–2024
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease
Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua et al. · Journal of Medicinal Chemistry · 2024 · 72 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +15
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
Yugendar R. Alugubelli, Zhi Geng, Kai S. Yang et al. · European Journal of Medicinal Chemistry · 2022 · 52 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacotherapy +16
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
Yuying Ma, Kai S. Yang, Zhi Geng et al. · European Journal of Medicinal Chemistry · 2022 · 42 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
Zhi Geng, Sandeep Atla, Namir Shaabani et al. · Journal of Medicinal Chemistry · 2023 · 23 citations · Full text
Life Sciences, Medicinal Chemistry, Molecular Biology +15
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
Kaustav Khatua, Yugendar R. Alugubelli, Kai S. Yang et al. · Antiviral Research · 2024 · 11 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
1–5 of 5